171 Influence of candesartan on myocardial perfusion measured by use of quantitative myocardial contrast echocardiography (QMCE): A substudy of the candesartan cilexetil in heart failure assessment of reduction in mortality and morbidity (CHARM) -program

Mortality And Morbidity ◽

171 Influence of candesartan on myocardial perfusion measured by use of quantitative myocardial contrast echocardiography (QMCE): A substudy of the candesartan cilexetil in heart failure assessment of reduction in mortality and morbidity (CHARM) -program

European Journal of Echocardiography ◽

10.1016/s1525-2167(99)80005-5 ◽

1999 ◽

Vol 1 ◽

pp. S3-S3

Author(s):

J WUNDERLICH ◽

G BRAND ◽

W MEYERSABELLEK ◽

N POGACIC ◽

H POLZ ◽

...

Keyword(s):

Heart Failure ◽

Myocardial Perfusion ◽

Candesartan Cilexetil ◽

Mortality And Morbidity ◽

257 Assessment of myocardial perfusion in acute myocardial infarction by non-invasive myocardial contrast echocardiography, contrast magnetic resonance and SPECT

European Journal of Echocardiography ◽

10.1016/s1525-2167(99)80065-1 ◽

1999 ◽

Vol 1 ◽

pp. S19-S19

Author(s):

A IOMBARDO ◽

L GALIUTO ◽

L NATALE ◽

A GIORDANO ◽

C IERARDI ◽

...

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Magnetic Resonance ◽

Myocardial Perfusion ◽

Non Invasive ◽

Contrast Magnetic Resonance

P607 Detection of coronary artery disease in heart failure: role of myocardial contrast echocardiography in patients with first presentation of heart failure without acute myocardial infarction

European Heart Journal ◽

10.1016/s0195-668x(03)94045-0 ◽

2003 ◽

Vol 24 (5) ◽

pp. 104

Author(s):

R JANARDHANAN

Keyword(s):

Myocardial Infarction ◽

Heart Failure ◽

Coronary Artery Disease ◽

Acute Myocardial Infarction ◽

Coronary Artery ◽

Artery Disease

P600 Absolute quantification of myocardial perfusion using real-time myocardial contrast echocardiography: an in vitro study and first in vivo results

European Heart Journal ◽

10.1016/s0195-668x(03)94038-3 ◽

2003 ◽

Vol 24 (5) ◽

pp. 102 ◽

Cited By ~ 1

Author(s):

R VOGEL

Keyword(s):

Myocardial Perfusion ◽

Real Time ◽

Myocardial Contrast Echocardiography

In Vitro Study ◽

Absolute Quantification ◽

Vitro Study ◽

Faculty Opinions recommendation of Association of heart rate and outcomes in a broad spectrum of patients with chronic heart failure: results from the CHARM (Candesartan in Heart Failure: Assessment of Reduction in Mortality and morbidity) program.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717951152.793456454 ◽

2012 ◽

Author(s):

Marrick Kukin ◽

Edgar Argulian

Keyword(s):

Heart Failure ◽

Heart Rate ◽

Chronic Heart Failure ◽

Broad Spectrum ◽

Mortality And Morbidity ◽

Failure Assessment ◽

Spectrum Of Patients

Assessment of myocardial perfusion abnormalities by intravenous myocardial contrast echocardiography with harmonic power Doppler imaging: comparison with positron emission tomography

Heart ◽

10.1136/heart.89.2.145 ◽

2003 ◽

Vol 89 (2) ◽

pp. 145-149 ◽

Cited By ~ 18

Author(s):

T Muro

Keyword(s):

Positron Emission Tomography ◽

Myocardial Perfusion ◽

Power Doppler ◽

Emission Tomography ◽

Doppler Imaging ◽

Positron Emission ◽

Power Doppler Imaging ◽

Harmonic Power

Myocardial contrast echocardiography for assessment of myocardial perfusion at rest in a patient with left main coronary artery stenosis

Zeitschrift für Kardiologie ◽

10.1007/s00392-003-0972-x ◽

2003 ◽

Vol 92 (10) ◽

pp. 876-883 ◽

Cited By ~ 1

Author(s):

A. Hagendorff ◽

D. Pfeiffer ◽

T. Rother ◽

H. Becher

Keyword(s):

Coronary Artery ◽

Myocardial Perfusion ◽

Left Main Coronary Artery ◽

Coronary Artery Stenosis ◽

Artery Stenosis ◽

Left Main ◽

Main Coronary Artery Stenosis

Clinical Correlates and Consequences of Anemia in a Broad Spectrum of Patients With Heart Failure: Results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Yearbook of Cardiology ◽

10.1016/s0145-4145(08)70204-1 ◽

2007 ◽

Vol 2007 ◽

pp. 325-327

Author(s):

M.D. Cheitlin

Keyword(s):

Heart Failure ◽

Broad Spectrum ◽

Mortality And Morbidity ◽

Clinical Correlates ◽

Failure Assessment ◽

Patients With Heart Failure ◽

Spectrum Of Patients

Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and design

Journal of Cardiac Failure ◽

10.1016/s1071-9164(99)90013-1 ◽

1999 ◽

Vol 5 (3) ◽

pp. 276-282 ◽

Cited By ~ 181

Author(s):

Karl Swedberg ◽

Marc Pfeffer ◽

Chris Granger ◽

Peter Held ◽

John Mcmurray ◽

...

Keyword(s):

Heart Failure ◽

Mortality And Morbidity ◽

1108-109 Low hemoglobin is an independent predictor of adverse fatal and nonfatal outcomes in both reduced and preserved systolic function chronic heart failure: Findings from the candesartan in heart failure assessment of reduction in mortality and morbidity program (CHARM)

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(04)90836-4 ◽

2004 ◽

Vol 43 (5) ◽

pp. A197

Author(s):

John J McMurray ◽

Chim C Lang ◽

Karl Swedberg ◽

Jan Östergren ◽

Christopher B Granger ◽

...

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Independent Predictor ◽

Systolic Function ◽

Mortality And Morbidity ◽